Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01652716

Public ClinicalTrials.gov record NCT01652716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Exenatide Twice Daily in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the effect on glycemic control (HbA1c) of exenatide suspension administered once weekly to that achieved by exenatide administered twice daily for 28 weeks in subjects with type 2 diabetes mellitus. To examine the long-term (52 weeks of treatment) safety and effect on glucose control of exenatide suspension administered once weekly in subjects with type 2 diabetes mellitus.

Study identification

NCT ID
NCT01652716
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
377 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2012
Primary completion
Jul 31, 2014
Completion
Jul 31, 2014
Last update posted
Jul 2, 2018

2013 – 2014

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
55
Facility City State ZIP Site status
Research Site Muscle Shoals Alabama 35662
Research Site Mesa Arizona 85206
Research Site Phoenix Arizona 85020
Research Site Little Rock Arkansas 72205
Research Site Escondido California 92026
Research Site Garden Grove California 92844
Research Site Lomita California 90717
Research Site Los Angeles California 90015
Research Site Santa Ana California 92705
Research Site Spring Valley California 91978
Research Site Walnut Creek California 94598
Research Site Denver Colorado 80220
Research Site Coral Gables Florida 33134
Research Site DeLand Florida 32720
Research Site Kissimmee Florida 34741
Research Site Miami Florida 33156
Research Site Orlando Florida 32806
Research Site Oviedo Florida 32765
Research Site Palm Harbor Florida 34684
Research Site Ponte Vedra Florida 32081
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60616
Research Site Lexington Kentucky 40503
Research Site Paducah Kentucky 42003
Research Site Lake Charles Louisiana 70601
Research Site Columbia Maryland 21045
Research Site Elkridge Maryland 21075
Research Site Hyattsville Maryland 20782
Research Site New Bedford Massachusetts 02740
Research Site Detroit Michigan 48202
Research Site Troy Michigan 48098
Research Site Edina Minnesota 55435
Research Site Port Gibson Mississippi 39150
Research Site St Louis Missouri 63128
Research Site Butte Montana 59701
Research Site Henderson Nevada 89052
Research Site Endwell New York 13760
Research Site New Windsor New York 12553
Research Site Greensboro North Carolina 27408
Research Site Cincinnati Ohio 45219
Research Site Cincinnati Ohio 45227
Research Site Columbus Ohio 43213
Research Site Oklahoma City Oklahoma 73103
Research Site Oklahoma City Oklahoma 73112
Research Site Portland Oregon 97239
Research Site Harleysville Pennsylvania 19438
Research Site Charleston South Carolina 29407
Research Site Mt. Pleasant South Carolina 29464
Research Site Dallas Texas 75230
Research Site Houston Texas 77062
Research Site San Antonio Texas 78205
Research Site Murray Utah 84123
Research Site Salt Lake City Utah 84107
Research Site Manassas Virginia 20110
Research Site Norfolk Virginia 23502
Research Site Richmond Virginia 23294
Research Site Olympia Washington 98502
Research Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01652716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2018 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01652716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →